Clinical Trials in Entebbe, Uganda
3 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled30 locationsNCT07071623
Recruiting
Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
COVID19COVIDSARS-CoV2 infection
University of Minnesota820 enrolled66 locationsNCT04910269
Recruiting
An International Observational Study of Adults With Acute Infection
Infectious Disease
University of Minnesota1,500 enrolled47 locationsNCT07069400
Recruiting
Phase 3
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
HIV Infections
ViiV Healthcare3,508 enrolled34 locationsNCT06134362